Clinical trial
Sperm Selection by Microfluidic Separation Improves Embryo Quality
NCT03085433 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sperm Selection by Microfluidic Separation Improves Embryo Quality
- Lead sponsor
- University of California, San Francisco
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 20, 2017
- Completion date
- April 30, 2022
- Enrollment
- 393 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
embryo quality, fertility disorders, infertility, infertility unexplained, infertility, male, sperm dna fragmentation